{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-B33JUDBL/db15--4ccea5423afa4e40-c1caeb2c9bf-3/PDF","dcterms:extent":"24254 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-B33JUDBL/2c3d7e2b-b09e-4ba9-b5dc-1c2159190cc0/TEXT","dcterms:extent":"0 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-B33JUDBL/bff85947-e27f-45ac-b7be-a0f57385c33f/WEB","dcterms:extent":"0 KB"}],"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:DOC-B33JUDBL","dcterms:issued":"2020","dc:contributor":["Božič, Borut","Čučnik, Saša","Praprotnik, Sonja","Štrukelj, Borut","Tomšič, Matija"],"dc:creator":"Ogrič, Manca","dc:format":{"@xml:lang":"sl","#text":"XII, 173 str."},"dc:identifier":["COBISSID:46272515","PID:https://repozitorij.uni-lj.si/IzpisGradiva.php?id=137113","URN:URN:NBN:SI:doc-B33JUDBL"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"M. Ogrič"},"dc:source":{"@xml:lang":"sl","#text":"visokošolska dela"},"dc:subject":[{"@xml:lang":"sl","#text":"adalimumab"},{"@xml:lang":"sl","#text":"avtoimunske bolezni"},{"@xml:lang":"sl","#text":"biološka zdravila"},{"@xml:lang":"en","#text":"immunogenicity"},{"@xml:lang":"sl","#text":"imunogenost"},{"@xml:lang":"sl","#text":"infliksimab"},{"@xml:lang":"en","#text":"infliximab"},{"@xml:lang":"sl","#text":"koronarne arterije"},{"@xml:lang":"sl","#text":"protitelesa"},{"@xml:lang":"sl","#text":"vnetno stimulirane humane endotelijske celice"}],"dc:title":{"@xml:lang":"sl","#text":"Imunogenost infliksimaba in adalimumaba ter njun vpliv na vnetno stimulirane humane endotelijske celice koronarne arterije| doktorska disertacija| Immunogenicity of infliximab and adalimumab and their influence on inflammatory stimulated human coronary artery endothelial cells|"},"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"visokošolska dela"},{"@xml:lang":"en","#text":"theses and dissertations"},{"@rdf:resource":"http://www.wikidata.org/entity/Q1266946"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:DOC-B33JUDBL","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:DOC-B33JUDBL"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:DOC-B33JUDBL/db15--4ccea5423afa4e40-c1caeb2c9bf-3/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Univerza v Ljubljani, Fakulteta za farmacijo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:DOC-B33JUDBL/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:DOC-B33JUDBL"}}}}